ReviewFEBS open bio2026
Adenosine triphosphate as a modulator of protein interactions and stability.
Review in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beyond its classical role as the cellular energy currency, adenosine triphosphate (ATP) can directly modulate protein stability, solubility and self-assembly through weak nonspecific interactions. Here, we summarise the current experimental and theoretical understanding of noncanonical ATP-protein interactions and their implications for folding, aggregation and phase stability. Recent studies show that ATP interacts primarily with positively charged residues such as lysine (Lys) and arginine (Arg) via electrostatic and hydrogen-bonding interactions, with additional cation-π or π-π contacts in some systems. These interactions modulate protein folding, conformational stability and aggregation by shifting the balance between folded and unfolded states. For intrinsically disordered and amyloidogenic proteins, ATP acts as a concentration-dependent regulator that can promote, suppress or remodel phase-separated condensates and fibrillar assemblies depending on protein sequence, ATP concentration and solution conditions. In natively folded proteins, ATP influences protein-protein interactions and phase behaviour, often enhancing colloidal stability and suppressing aggregation. Complexation with Mg
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.